S8 Ep59: Trent Talks Through Potential Clinical Applications and Future Directions for MRD in GIST
S8 Ep59: Trent Talks Through Potential Clinical Applications and Future Directions for MRD in GIST
Dr Trent discusses the current role and significance of using MRD in gastrointestinal stromal tumor, current guidelines ... Read more
31 Jul 2023
•
10mins
S8 Ep59: Camidge and Abbott Discuss the Role of the Biotechnology Analyst in Drug Development
S8 Ep59: Camidge and Abbott Discuss the Role of the Biotechnology Analyst in Drug Development
In this episode of ‘How This is Building Me,’ Drs Camidge and Abbott discuss the road from bench scientist to biotechnol... Read more
27 Jul 2023
•
42mins
Similar Podcasts
S8 Ep58: Lunning and Kamdar Debate the Role of Pola-R-CHP in Treatment-Naïve DLBCL
S8 Ep58: Lunning and Kamdar Debate the Role of Pola-R-CHP in Treatment-Naïve DLBCL
Dr Lunning sits down with Manali Kamdar, MD, of the University of Colorado, to discuss the design of the POLARIX trial, ... Read more
24 Jul 2023
•
20mins
S8 Ep57: Khan and Kwendakwema Discuss Financial Toxicity in Patients With Cancer
S8 Ep57: Khan and Kwendakwema Discuss Financial Toxicity in Patients With Cancer
Drs Khan and Kwendakwema discuss the methods and design of two studies investigating adverse financial events in patient... Read more
20 Jul 2023
•
12mins
S8 Ep56: FDA Approval Insights: Talazoparib Plus Enzalutamide in HRR Gene–Mutated mCRPC
S8 Ep56: FDA Approval Insights: Talazoparib Plus Enzalutamide in HRR Gene–Mutated mCRPC
Dr Agarwal discusses the significance of the FDA approval of talazoparib plus enzalutamide in HRR gene–mutated mCRPC, ke... Read more
17 Jul 2023
•
13mins
S8 Ep56: Lunning and Abramson Spotlight Developments and Challenges in LBCL Research and Management
S8 Ep56: Lunning and Abramson Spotlight Developments and Challenges in LBCL Research and Management
Dr Lunning sits down with Jeremy Abramson, MD, of Massachusetts General Hospital, to discuss treatment options for patie... Read more
13 Jul 2023
•
32mins
S8 Ep55: FDA Approval Insights: Avapritinib in Indolent Systemic Mastocytosis
S8 Ep55: FDA Approval Insights: Avapritinib in Indolent Systemic Mastocytosis
Dr Gotlib discusses the significance of the FDA approval of avapritinib in indolent systemic mastocytosis, key findings ... Read more
10 Jul 2023
•
13mins
S8 Ep55: King Describes Unmet Needs and the Role of Surgical Resection in Residual Non-RP Testicular Cancer
S8 Ep55: King Describes Unmet Needs and the Role of Surgical Resection in Residual Non-RP Testicular Cancer
Dr King discusses the need for improved guidance when determining the appropriate management strategy for patients with ... Read more
6 Jul 2023
•
10mins
S8 Ep55: Kremyanskaya Highlights the Benefits of BET Inhibitors in Myelofibrosis
S8 Ep55: Kremyanskaya Highlights the Benefits of BET Inhibitors in Myelofibrosis
Dr Kremyanskaya discusses the results from cohort 1 of the MANIFEST trial in treatment-naïve myelofibrosis, differentiat... Read more
3 Jul 2023
•
12mins
S8 Ep55: Short Shares Post-Conference Perspectives in Acute Lymphoblastic Leukemia From ASCO and EHA 2023
S8 Ep55: Short Shares Post-Conference Perspectives in Acute Lymphoblastic Leukemia From ASCO and EHA 2023
Dr Short discusses data in acute lymphoblastic leukemia that were presented at the 2023 ASCO Annual Meeting and EHA Cong... Read more
29 Jun 2023
•
13mins